Xenia Michail | Associate Director of Pharmacovigilance
Teva

With over a decade of experience in pharmacovigilance, Xenia possesses a deep understanding of drug safety processes and risk management strategies. She is dedicated in building strong relationships with cross-functional teams and regulatory authorities to implement effective safety measures and drive continuous improvement in patient care while prioritizing patient safety. 
At Teva, Xenia is the Local Qualified Person for Pharmacovigilance in Greece and also serves as a SEE Sub-Cluster Manager for Greece, Cyprus, Malta, Bulgaria, Serbia, Bosnia-Herzegovina, and North Macedonia.
As a speaker at the World Patient Safety Congress Europe 2026, Xenia will share her insights and expertise on addressing key challenges for safety professionals in the ever-evolving healthcare landscape. Attendees can expect to gain actionable strategies and practical solutions from Xenia's session, informed by her passion for patient-centric care.